Literature DB >> 29218457

Phenotypical change of tumor-associated macrophages in metastatic lesions of clear cell renal cell carcinoma.

Takanobu Motoshima1,2, Yuji Miura3, Nanako Wakigami1, Natsuki Kusada1, Toshimi Takano3, Naoko Inoshita4, Toshikazu Okaneya5, Yutaka Sugiyama2, Tomomi Kamba2, Motohiro Takeya1, Yoshihiro Komohara6.   

Abstract

Macrophages are the main immune cells of the tumor microenvironment in clear cell renal cell carcinoma (ccRCC). A high density of CD163+ or CD204+ tumor-associated macrophages (TAMs), rather than the density of total TAMs, is known to be linked to poor clinical outcome. In the present study, we investigated the phenotypical differences between the paired primary and metastatic lesions in ccRCC cases. Using immunostaining, the densities of CD163+ and CD204+ TAMs in metastatic lesions were found to be significantly lower compared to primary lesions, although the total number of TAMs was increased in metastatic lesions. Since CD163 and CD204 are considered to be the markers of an M2/protumor phenotype in macrophages, TAMs in metastatic lesions are suggested to have a greater M1/inflammatory function compared with those from primary lesions. These findings give new insights in regard to the immunological status of metastatic lesions of ccRCC.

Entities:  

Keywords:  CD163; CD204; Iba1; Metastatic; TAM

Mesh:

Substances:

Year:  2017        PMID: 29218457     DOI: 10.1007/s00795-017-0174-7

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  26 in total

1.  Loss of BAP1 protein expression in the first metastatic site predicts prognosis in patients with clear cell renal cell carcinoma.

Authors:  Yuji Miura; Naoko Inoshita; Masaomi Ikeda; Yu Miyama; Ryosuke Oki; Suguru Oka; Chihiro Kondoh; Yukinori Ozaki; Yuko Tanabe; Kazuhiro Kurosawa; Shinji Urakami; Tadasu Kohno; Toshikazu Okaneya; Toshimi Takano
Journal:  Urol Oncol       Date:  2017-03-09       Impact factor: 3.498

Review 2.  Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy.

Authors:  Yoshihiro Komohara; Yukio Fujiwara; Koji Ohnishi; Motohiro Takeya
Journal:  Adv Drug Deliv Rev       Date:  2015-11-24       Impact factor: 15.470

Review 3.  CAFs and TAMs: maestros of the tumour microenvironment.

Authors:  Yoshihiro Komohara; Motohiro Takeya
Journal:  J Pathol       Date:  2016-11-24       Impact factor: 7.996

Review 4.  A Breakthrough: Macrophage-Directed Cancer Immunotherapy.

Authors:  Charles D Mills; Laurel L Lenz; Robert A Harris
Journal:  Cancer Res       Date:  2016-01-15       Impact factor: 12.701

Review 5.  The role of myeloid cells in cancer therapies.

Authors:  Camilla Engblom; Christina Pfirschke; Mikael J Pittet
Journal:  Nat Rev Cancer       Date:  2016-07       Impact factor: 60.716

6.  Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

Authors:  Y Komohara; K Ohnishi; J Kuratsu; M Takeya
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

Review 7.  Tumour-associated macrophages as treatment targets in oncology.

Authors:  Alberto Mantovani; Federica Marchesi; Alberto Malesci; Luigi Laghi; Paola Allavena
Journal:  Nat Rev Clin Oncol       Date:  2017-01-24       Impact factor: 66.675

Review 8.  Immune cell promotion of metastasis.

Authors:  Takanori Kitamura; Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Nat Rev Immunol       Date:  2015-02       Impact factor: 53.106

9.  An Immune Atlas of Clear Cell Renal Cell Carcinoma.

Authors:  Stéphane Chevrier; Jacob Harrison Levine; Vito Riccardo Tomaso Zanotelli; Karina Silina; Daniel Schulz; Marina Bacac; Carola Hermine Ries; Laurie Ailles; Michael Alexander Spencer Jewett; Holger Moch; Maries van den Broek; Christian Beisel; Michael Beda Stadler; Craig Gedye; Bernhard Reis; Dana Pe'er; Bernd Bodenmiller
Journal:  Cell       Date:  2017-05-04       Impact factor: 41.582

10.  CCL2 as a potential therapeutic target for clear cell renal cell carcinoma.

Authors:  Ryuichiro Arakaki; Toshinari Yamasaki; Toru Kanno; Noboru Shibasaki; Hiromasa Sakamoto; Noriaki Utsunomiya; Takayuki Sumiyoshi; Shinsuke Shibuya; Tatsuaki Tsuruyama; Eijiro Nakamura; Osamu Ogawa; Tomomi Kamba
Journal:  Cancer Med       Date:  2016-09-26       Impact factor: 4.452

View more
  8 in total

Review 1.  The tumor microenvironment in renal cell cancer.

Authors:  James W Mier
Journal:  Curr Opin Oncol       Date:  2019-05       Impact factor: 3.645

2.  Predictive value of preoperative monocyte-lymphocyte ratio among patients with localized clear renal cell carcinoma of ≤7 cm on preoperative imaging.

Authors:  Ahmed Elghiaty; Jongchan Kim; Won Sik Jang; Jee Soo Park; Ji Eun Heo; Koon Ho Rha; Young Deuk Choi; Won Sik Ham
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

3.  Immune infiltration in renal cell carcinoma.

Authors:  Shichao Zhang; Erdong Zhang; Jinhua Long; Zuquan Hu; Jian Peng; Lina Liu; Fuzhou Tang; Long Li; Yan Ouyang; Zhu Zeng
Journal:  Cancer Sci       Date:  2019-04-07       Impact factor: 6.716

4.  Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer.

Authors:  Yunjie He; Siying Zhou; Fei Deng; Shujie Zhao; Wenquan Chen; Dandan Wang; Xiu Chen; Juncheng Hou; Jian Zhang; Wei Zhang; Li Ding; Jinhai Tang; Zuomin Zhou
Journal:  Aging (Albany NY)       Date:  2019-12-04       Impact factor: 5.682

5.  Bioinformatics Analysis of Prognostic Value of SPC24 in ccRCC and Pan-Cancer.

Authors:  Jipeng Zhang; Xinlei Chen; Jirong Wang; Pengfei Zhang; Xue Han; Youzhi Zhang; Yonghua Wang; Xiaokun Yang
Journal:  Int J Gen Med       Date:  2022-01-23

Review 6.  From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma.

Authors:  Jonathan Anker; Justin Miller; Nicole Taylor; Natasha Kyprianou; Che-Kai Tsao
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

7.  Data Mining of Prognostic Microenvironment-Related Genes in Clear Cell Renal Cell Carcinoma: A Study with TCGA Database.

Authors:  Bin Chen; Wei Chen; Jing Jin; Xueping Wang; Yifang Cao; Yi He
Journal:  Dis Markers       Date:  2019-10-30       Impact factor: 3.434

8.  Detecting Immune Response to Therapies Targeting PDL1 and BRAF by Using Ferumoxytol MRI and Macrin in Anaplastic Thyroid Cancer.

Authors:  Thomas S C Ng; Viswanath Gunda; Ran Li; Mark Prytyskach; Yoshiko Iwamoto; Rainer H Kohler; Sareh Parangi; Ralph Weissleder; Miles A Miller
Journal:  Radiology       Date:  2020-10-27       Impact factor: 11.105

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.